Royal Bank of Canada’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$71K Buy
20,960
+20,959
+2,095,900% +$71K ﹤0.01% 5410
2025
Q1
$0 Buy
+1
New ﹤0.01% 6533
2024
Q4
Sell
-11,294
Closed -$28K 6498
2024
Q3
$28K Buy
+11,294
New +$28K ﹤0.01% 5511
2024
Q2
Sell
-784
Closed -$2K 6812
2024
Q1
$2K Sell
784
-6,280
-89% -$16K ﹤0.01% 6225
2023
Q4
$52K Buy
7,064
+2,507
+55% +$18.5K ﹤0.01% 5438
2023
Q3
$35K Buy
4,557
+3,090
+211% +$23.7K ﹤0.01% 5473
2023
Q2
$15K Buy
1,467
+1,462
+29,240% +$14.9K ﹤0.01% 5871
2023
Q1
$0 Sell
5
-76
-94% ﹤0.01% 6778
2022
Q4
$0 Buy
+81
New ﹤0.01% 6920
2022
Q2
Sell
-1,167
Closed -$8K 6993
2022
Q1
$8K Sell
1,167
-795
-41% -$5.45K ﹤0.01% 6566
2021
Q4
$32K Buy
1,962
+1,090
+125% +$17.8K ﹤0.01% 6063
2021
Q3
$23K Buy
+872
New +$23K ﹤0.01% 6105